189 related articles for article (PubMed ID: 8339220)
1. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.
Kushima M; Kushima R; Hattori T; Tomoyoshi T
Urol Res; 1995; 23(6):381-6. PubMed ID: 8788276
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma.
Yu DS; Wang J; Chang SY; Ma CP
Eur Urol; 1991; 20(3):227-31. PubMed ID: 1823046
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
7. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
12. [Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].
Nagamori S
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):593-600. PubMed ID: 2374332
[TBL] [Abstract][Full Text] [Related]
13. In vivo aneuploidization during the expansion of renal adenocarcinoma.
Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
[TBL] [Abstract][Full Text] [Related]
14. DNA content in renal cell carcinoma with reference to tumor heterogeneity.
Ljungberg B; Stenling R; Roos G
Cancer; 1985 Aug; 56(3):503-8. PubMed ID: 4005812
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of renal cell carcinoma].
Lü GH
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]